Token导航 LogoToken导航

Agent Skill · 研究检索

tooluniverse-rare-disease-diagnosis(工具宇宙罕见病诊断)

tooluniverse-rare-disease-diagnosis 用于查找、检索和筛选相关信息,适合在 Codex、Claude、Cursor、Gemini CLI 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

tooluniverse-rare-disease-diagnosis 是研究检索类 Agent Skill,可用宿主为 Codex、Claude、Cursor、Gemini CLI,通过GitHub 仓库获取,权限为需要联网;许可证信息还不明确,第三方扫描有提醒项,按安装量在研究检索类的 73,675 个 Skill 里排第 65,351。

总安装 282周安装 12GitHub Stars 971下载 99核验 2026-05-01

安装说明

本站只整理中文说明,不托管安装包,也不代用户安装。
GitHub
许可证
unknown

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:tooluniverse-rare-disease-diagnosis(工具宇宙罕见病诊断)
来源仓库:https://github.com/wu-yc/labclaw
仓库路径:skills/tooluniverse-rare-disease-diagnosis
安装命令:
npx skills add https://github.com/wu-yc/labclaw --skill tooluniverse-rare-disease-diagnosis
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 npx skills 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

skills.shnpx skills
npx skills add https://github.com/wu-yc/labclaw --skill tooluniverse-rare-disease-diagnosis

这个 Skill 是做什么的

研究检索类 Skill 主要解决「找资料、核对事实、把来源整理清楚」的问题,通常会让助手先检索再总结。

用于罕见病诊断相关数据检索,支持在临床遗传学中获取症状-基因关联和鉴别诊断信息。适合在 Codex、Claude、Cursor、Gemini CLI 中执行表型匹配和候选基因筛选任务。通过 npx skills add 命令从 GitHub 安装,需确认仓库权限及是否涉及网络访问或外部 API 调用。

建议在使用前核实数据来源更新频率,避免依赖过期或未经验证的信息。注意该技能主要用于信息检索,不直接提供诊断结论,需结合临床评估使用。

来源仓库内路径:skills/tooluniverse-rare-disease-diagnosis

上手步骤

4 步
  1. 1

    确认自己的宿主工具

    公开资料标注支持 Codex、Claude、Cursor、Gemini CLI;先确认自己用的是其中之一,再按对应工具的 Skills 目录放置。

  2. 2

    拿到安装命令

    可以直接复制的命令是 npx skills add https://github.com/wu-yc/labclaw --skill tooluniverse-rare-diseas…;命令里的占位符换成自己的路径或密钥再执行。

  3. 3

    安装后重启宿主

    命令执行完要完全退出宿主工具再打开,让新装的 Skill 被重新扫描到,否则列表里可能看不到。

  4. 4

    按最小权限试用

    它需要需要联网,先在测试目录或测试账号里跑,确认没问题再放到正式项目。

常见问题

6 条

tooluniverse-rare-disease-diagnosis 怎么安装?

在终端执行 npx skills add https://github.com/wu-yc/labclaw --skill tooluniverse-rare-disease-diagnosi…。装完完全退出宿主工具再打开,让它重新扫描本地 Skill。

tooluniverse-rare-disease-diagnosis 支持哪些 AI 工具?

公开资料标注支持 Codex、Claude、Cursor、Gemini CLI。其他工具只要能读取本地 Skill 目录,一般也能手动放进去,但要自己确认触发方式是否一致。

tooluniverse-rare-disease-diagnosis 需要什么权限?

权限级别是需要联网。该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

tooluniverse-rare-disease-diagnosis 是免费的吗?

公开资料没有标注明确许可证,收费和商用限制都无法确认。正式使用前请到来源仓库核对授权说明。

tooluniverse-rare-disease-diagnosis 用的人多吗?

公开数据是累计安装 282 次,近一周安装 12 次,下载 99 次,GitHub 971 星。这些数字来自第三方目录统计,只能当作热度参考,不代表质量或安全性。

tooluniverse-rare-disease-diagnosis 安全吗?

第三方扫描有提醒项,说明存在需要人工确认的行为。安装前请打开源码看清它读了什么、联网到哪里。

值得选的地方和要先想清楚的地方

值得选的地方

  • 同时适配 4 种工具,换客户端不用重新找替代品。

先想清楚的地方

  • 许可证没有明确标注,能不能商用、能不能再分发都不确定。
  • 第三方扫描存在提醒项或未通过项,需要人工逐条确认。
  • 第三方目录整理,版本更新和行为细节以来源仓库为准。

适不适合你

更适合

  • 已经在用 Codex,想直接扩展它能力的人。
  • 需要处理研究检索类任务、又不想每次都手写提示词的人。

不太适合

  • 需要明确授权才能用到公司项目里的场景。
  • 需要厂商级技术支持和 SLA 的生产系统。

研究检索类 Skill 对比

6 个同类
Skill总安装GitHub 星权限许可证扫描
find-skills

寻找技能 · Codex、Claude

31,199,81316,486操作浏览器MIT有提醒
self-improving-agent

自我改进 Agent · OpenClaw

16,464,0023,396接触敏感数据MIT-0通过
soultrace

灵魂追踪 · Codex、Claude

7,588,94412需要联网未明确有提醒
self-improving

自我完善 · OpenClaw

6,829,2841,046需要联网MIT-0通过
microsoft-foundry

微软代工厂 · Codex、Claude

6,614,144764调用外部服务未明确有提醒
tooluniverse-rare-disease-diagnosis

工具宇宙罕见病诊断 · 本页

282971需要联网未明确有提醒

按安装量取同分类前几名;数字来自第三方目录统计,只作热度参考,不代表质量结论。

SKILL.md 原文

Rare Disease Diagnosis Advisor

Systematic diagnosis support for rare diseases using phenotype matching, gene panel prioritization, and variant interpretation across Orphanet, OMIM, HPO, ClinVar, and structure-based analysis.

KEY PRINCIPLES:

  1. Report-first approach - Create report file FIRST, update progressively
  2. Phenotype-driven - Convert symptoms to HPO terms before searching
  3. Multi-database triangulation - Cross-reference Orphanet, OMIM, OpenTargets
  4. Evidence grading - Grade diagnoses by supporting evidence strength
  5. Actionable output - Prioritized differential diagnosis with next steps
  6. Genetic counseling aware - Consider inheritance patterns and family history
  7. English-first queries - Always use English terms in tool calls (phenotype descriptions, gene names, disease names), even if the user writes in another language. Only try original-language terms as a fallback. Respond in the user's language

When to Use

Apply when user asks:

  • "Patient has [symptoms], what rare disease could this be?"
  • "Unexplained developmental delay with [features]"
  • "WES found VUS in [gene], is this pathogenic?"
  • "What genes should we test for [phenotype]?"
  • "Differential diagnosis for [rare symptom combination]"

Critical Workflow Requirements

1. Report-First Approach (MANDATORY)

  1. Create the report file FIRST:

- File name: [PATIENT_ID]_rare_disease_report.md - Initialize with all section headers - Add placeholder text: [Researching...]

  1. Progressively update as you gather data
  2. Output separate data files:

- [PATIENT_ID]_gene_panel.csv - Prioritized genes for testing - [PATIENT_ID]_variant_interpretation.csv - If variants provided

2. Citation Requirements (MANDATORY)

Every finding MUST include source:

### Candidate Disease: Marfan Syndrome
- **ORPHA**: ORPHA:558
- **OMIM**: 154700
- **Phenotype match**: 85% (17/20 HPO terms)
- **Inheritance**: AD
- **Gene**: FBN1

*Source: Orphanet via `Orphanet_558`, OMIM via `OMIM_get_entry`*

Phase 0: Tool Verification

CRITICAL: Verify tool parameters before calling.

Known Parameter Corrections

ToolWRONG ParameterCORRECT Parameter
OpenTargets_get_associated_diseases_by_target_ensemblIdensemblIDensemblId
ClinVar_get_variant_by_idvariant_idid
MyGene_query_genesgeneq
gnomAD_get_variant_frequenciesvariantvariant_id

Workflow Overview

Phase 1: Phenotype Standardization
├── Convert symptoms to HPO terms
├── Identify core vs. variable features
└── Note age of onset, inheritance hints
    ↓
Phase 2: Disease Matching
├── Orphanet phenotype search
├── OMIM clinical synopsis match
├── OpenTargets disease associations
└── OUTPUT: Ranked differential diagnosis
    ↓
Phase 3: Gene Panel Identification
├── Extract genes from top diseases
├── Cross-reference expression (GTEx)
├── Prioritize by evidence strength
└── OUTPUT: Recommended gene panel
    ↓
Phase 3.5: Expression & Tissue Context (NEW)
├── CELLxGENE: Cell-type specific expression
├── ChIPAtlas: Regulatory context (TF binding)
├── Tissue-specific gene networks
└── OUTPUT: Expression validation
    ↓
Phase 3.6: Pathway Analysis (NEW)
├── KEGG: Metabolic/signaling pathways
├── Reactome: Biological processes
├── IntAct: Protein-protein interactions
└── OUTPUT: Biological context
    ↓
Phase 4: Variant Interpretation (if provided)
├── ClinVar pathogenicity lookup
├── gnomAD population frequency
├── Protein domain/function impact
├── ENCODE/ChIPAtlas: Regulatory variant impact
└── OUTPUT: Variant classification
    ↓
Phase 5: Structure Analysis (for VUS)
├── NvidiaNIM_alphafold2 → Predict structure
├── Map variant to structure
├── Assess functional domain impact
└── OUTPUT: Structural evidence
    ↓
Phase 6: Literature Evidence (NEW)
├── PubMed: Published studies
├── BioRxiv/MedRxiv: Preprints
├── OpenAlex: Citation analysis
└── OUTPUT: Literature support
    ↓
Phase 7: Report Synthesis
├── Prioritized differential diagnosis
├── Recommended genetic testing
├── Next steps for clinician
└── OUTPUT: Final report

Phase 1: Phenotype Standardization

1.1 Convert Symptoms to HPO Terms

def standardize_phenotype(tu, symptoms_list):
    """Convert clinical descriptions to HPO terms."""
    hpo_terms = []

    for symptom in symptoms_list:
        # Search HPO for matching terms
        results = tu.tools.HPO_search_terms(query=symptom)
        if results:
            hpo_terms.append({
                'original': symptom,
                'hpo_id': results[0]['id'],
                'hpo_name': results[0]['name'],
                'confidence': 'exact' if symptom.lower() in results[0]['name'].lower() else 'partial'
            })

    return hpo_terms

1.2 Phenotype Categories

CategoryExamplesWeight
Core featuresAlways present in diseaseHigh
Variable featuresPresent in >50%Medium
Occasional featuresPresent in <50%Low
Age-specificOnset-dependentContext

1.3 Output for Report

## 1. Phenotype Analysis

### 1.1 Standardized HPO Terms

| Clinical Feature | HPO Term | HPO ID | Category |
|------------------|----------|--------|----------|
| Tall stature | Tall stature | HP:0000098 | Core |
| Long fingers | Arachnodactyly | HP:0001166 | Core |
| Heart murmur | Cardiac murmur | HP:0030148 | Variable |
| Joint hypermobility | Joint hypermobility | HP:0001382 | Core |

**Total HPO Terms**: 8
**Onset**: Childhood
**Family History**: Father with similar features (AD suspected)

*Source: HPO via `HPO_search_terms`*

Phase 2: Disease Matching

2.1 Orphanet Disease Search (NEW TOOLS)

def match_diseases_orphanet(tu, symptom_keywords):
    """Find rare diseases matching symptoms using Orphanet."""
    candidate_diseases = []

    # Search Orphanet by disease keywords
    for keyword in symptom_keywords:
        results = tu.tools.Orphanet_search_diseases(
            operation="search_diseases",
            query=keyword
        )
        if results.get('status') == 'success':
            candidate_diseases.extend(results['data']['results'])

    # Get genes for each disease
    for disease in candidate_diseases:
        orpha_code = disease.get('ORPHAcode')
        genes = tu.tools.Orphanet_get_genes(
            operation="get_genes",
            orpha_code=orpha_code
        )
        disease['genes'] = genes.get('data', {}).get('genes', [])

    return deduplicate_and_rank(candidate_diseases)

2.2 OMIM Cross-Reference (NEW TOOLS)

def cross_reference_omim(tu, orphanet_diseases, gene_symbols):
    """Get OMIM details for diseases and genes."""
    omim_data = {}

    # Search OMIM for each disease/gene
    for gene in gene_symbols:
        search_result = tu.tools.OMIM_search(
            operation="search",
            query=gene,
            limit=5
        )
        if search_result.get('status') == 'success':
            for entry in search_result['data'].get('entries', []):
                mim_number = entry.get('mimNumber')

                # Get detailed entry
                details = tu.tools.OMIM_get_entry(
                    operation="get_entry",
                    mim_number=str(mim_number)
                )

                # Get clinical synopsis (phenotype features)
                synopsis = tu.tools.OMIM_get_clinical_synopsis(
                    operation="get_clinical_synopsis",
                    mim_number=str(mim_number)
                )

                omim_data[gene] = {
                    'mim_number': mim_number,
                    'details': details.get('data', {}),
                    'clinical_synopsis': synopsis.get('data', {})
                }

    return omim_data

2.3 DisGeNET Gene-Disease Associations (NEW TOOLS)

def get_gene_disease_associations(tu, gene_symbols):
    """Get gene-disease associations from DisGeNET."""
    associations = {}

    for gene in gene_symbols:
        # Get diseases associated with gene
        result = tu.tools.DisGeNET_search_gene(
            operation="search_gene",
            gene=gene,
            limit=20
        )

        if result.get('status') == 'success':
            associations[gene] = result['data'].get('associations', [])

    return associations

def get_disease_genes_disgenet(tu, disease_name):
    """Get all genes associated with a disease."""
    result = tu.tools.DisGeNET_search_disease(
        operation="search_disease",
        disease=disease_name,
        limit=30
    )
    return result.get('data', {}).get('associations', [])

2.4 Phenotype Overlap Scoring

Match LevelScoreCriteria
Excellent>80%Most core + variable features match
Good60-80%Core features match, some variable
Possible40-60%Some overlap, needs consideration
Unlikely<40%Poor phenotype fit

2.5 Output for Report

## 2. Differential Diagnosis

### Top Candidate Diseases (Ranked by Phenotype Match)

| Rank | Disease | ORPHA | OMIM | Match | Inheritance | Key Gene(s) |
|------|---------|-------|------|-------|-------------|-------------|
| 1 | Marfan syndrome | 558 | 154700 | 85% | AD | FBN1 |
| 2 | Loeys-Dietz syndrome | 60030 | 609192 | 72% | AD | TGFBR1, TGFBR2 |
| 3 | Ehlers-Danlos, vascular | 286 | 130050 | 65% | AD | COL3A1 |
| 4 | Homocystinuria | 394 | 236200 | 58% | AR | CBS |

### DisGeNET Gene-Disease Evidence

| Gene | Associated Diseases | GDA Score | Evidence |
|------|---------------------|-----------|----------|
| FBN1 | Marfan syndrome, MASS phenotype | 0.95 | ★★★ Curated |
| TGFBR1 | Loeys-Dietz syndrome | 0.89 | ★★★ Curated |
| COL3A1 | vascular EDS | 0.91 | ★★★ Curated |

*Source: DisGeNET via `DisGeNET_search_gene`*

### Disease Details

#### 1. Marfan Syndrome (★★★)

**ORPHA**: 558 | **OMIM**: 154700 | **Prevalence**: 1-5/10,000

**Phenotype Match Analysis**:
| Patient Feature | Disease Feature | Match |
|-----------------|-----------------|-------|
| Tall stature | Present in 95% | ✓ |
| Arachnodactyly | Present in 90% | ✓ |
| Joint hypermobility | Present in 85% | ✓ |
| Cardiac murmur | Aortic root dilation (70%) | Partial |

**OMIM Clinical Synopsis** (via `OMIM_get_clinical_synopsis`):
- **Cardiovascular**: Aortic root dilation, mitral valve prolapse
- **Skeletal**: Scoliosis, pectus excavatum, tall stature
- **Ocular**: Ectopia lentis, myopia

**Diagnostic Criteria**: Ghent nosology (2010)
- Aortic root dilation/dissection + FBN1 mutation = Diagnosis
- Without genetic testing: systemic score ≥7 + ectopia lentis

**Inheritance**: Autosomal dominant (25% de novo)

*Source: Orphanet via `Orphanet_get_disease`, OMIM via `OMIM_get_entry`, DisGeNET*

Phase 3: Gene Panel Identification

3.1 Extract Disease Genes

def build_gene_panel(tu, candidate_diseases):
    """Build prioritized gene panel from candidate diseases."""
    genes = {}

    for disease in candidate_diseases:
        for gene in disease['genes']:
            if gene not in genes:
                genes[gene] = {
                    'symbol': gene,
                    'diseases': [],
                    'evidence_level': 'unknown'
                }
            genes[gene]['diseases'].append(disease['name'])

    return genes

3.1.1 ClinGen Gene-Disease Validity Check (NEW)

Critical: Always verify gene-disease validity through ClinGen before including in panel.

def get_clingen_gene_evidence(tu, gene_symbol):
    """
    Get ClinGen gene-disease validity and dosage sensitivity.
    ESSENTIAL for rare disease gene panel prioritization.
    """

    # 1. Gene-disease validity classification
    validity = tu.tools.ClinGen_search_gene_validity(gene=gene_symbol)

    validity_levels = []
    diseases_with_validity = []
    if validity.get('data'):
        for entry in validity.get('data', []):
            validity_levels.append(entry.get('Classification'))
            diseases_with_validity.append({
                'disease': entry.get('Disease Label'),
                'mondo_id': entry.get('Disease ID (MONDO)'),
                'classification': entry.get('Classification'),
                'inheritance': entry.get('Inheritance')
            })

    # 2. Dosage sensitivity (critical for CNV interpretation)
    dosage = tu.tools.ClinGen_search_dosage_sensitivity(gene=gene_symbol)

    hi_score = None
    ts_score = None
    if dosage.get('data'):
        for entry in dosage.get('data', []):
            hi_score = entry.get('Haploinsufficiency Score')
            ts_score = entry.get('Triplosensitivity Score')
            break

    # 3. Clinical actionability (return of findings context)
    actionability = tu.tools.ClinGen_search_actionability(gene=gene_symbol)
    is_actionable = (actionability.get('adult_count', 0) > 0 or
                     actionability.get('pediatric_count', 0) > 0)

    # Determine best evidence level
    level_priority = ['Definitive', 'Strong', 'Moderate', 'Limited', 'Disputed', 'Refuted']
    best_level = 'Not curated'
    for level in level_priority:
        if level in validity_levels:
            best_level = level
            break

    return {
        'gene': gene_symbol,
        'evidence_level': best_level,
        'diseases_curated': diseases_with_validity,
        'haploinsufficiency_score': hi_score,
        'triplosensitivity_score': ts_score,
        'is_actionable': is_actionable,
        'include_in_panel': best_level in ['Definitive', 'Strong', 'Moderate']
    }

def prioritize_genes_with_clingen(tu, gene_list):
    """Prioritize genes using ClinGen evidence levels."""

    prioritized = []
    for gene in gene_list:
        evidence = get_clingen_gene_evidence(tu, gene)

        # Score based on ClinGen classification
        score = 0
        if evidence['evidence_level'] == 'Definitive':
            score = 5
        elif evidence['evidence_level'] == 'Strong':
            score = 4
        elif evidence['evidence_level'] == 'Moderate':
            score = 3
        elif evidence['evidence_level'] == 'Limited':
            score = 1
        # Disputed/Refuted get 0

        # Bonus for haploinsufficiency score 3
        if evidence['haploinsufficiency_score'] == '3':
            score += 1

        # Bonus for actionability
        if evidence['is_actionable']:
            score += 1

        prioritized.append({
            **evidence,
            'priority_score': score
        })

    # Sort by priority score
    return sorted(prioritized, key=lambda x: x['priority_score'], reverse=True)

ClinGen Classification Impact on Panel:

ClassificationInclude in Panel?Priority
DefinitiveYES - mandatoryHighest
StrongYES - highly recommendedHigh
ModerateYESMedium
LimitedInclude but flagLow
DisputedExclude or separateAvoid
RefutedEXCLUDEDo not test
Not curatedUse other evidenceVariable

3.2 Gene Prioritization Criteria

PriorityCriteriaPoints
Tier 1Gene causes #1 ranked disease+5
Tier 2Gene causes multiple candidates+3
Tier 3ClinGen "Definitive" evidence+3
Tier 4Expressed in affected tissue+2
Tier 5Constraint score pLI >0.9+1

3.3 Expression Validation

def validate_expression(tu, gene_symbol, affected_tissue):
    """Check if gene is expressed in relevant tissue."""
    # Get Ensembl ID
    gene_info = tu.tools.MyGene_query_genes(q=gene_symbol, species="human")
    ensembl_id = gene_info.get('ensembl', {}).get('gene')

    # Check GTEx expression
    expression = tu.tools.GTEx_get_median_gene_expression(
        gencode_id=f"{ensembl_id}.latest"
    )

    return expression.get(affected_tissue, 0) > 1  # TPM > 1

3.4 Output for Report

## 3. Recommended Gene Panel

### 3.1 Prioritized Genes for Testing

| Priority | Gene | Diseases | Evidence | Constraint (pLI) | Expression |
|----------|------|----------|----------|------------------|------------|
| ★★★ | FBN1 | Marfan syndrome | Definitive | 1.00 | Heart, aorta |
| ★★★ | TGFBR1 | Loeys-Dietz 1 | Definitive | 0.98 | Ubiquitous |
| ★★★ | TGFBR2 | Loeys-Dietz 2 | Definitive | 0.99 | Ubiquitous |
| ★★☆ | COL3A1 | EDS vascular | Definitive | 1.00 | Connective tissue |
| ★☆☆ | CBS | Homocystinuria | Definitive | 0.00 | Liver |

### 3.2 Panel Design Recommendation

**Minimum Panel** (high yield): FBN1, TGFBR1, TGFBR2, COL3A1
**Extended Panel** (+differential): Add CBS, SMAD3, ACTA2

**Testing Strategy**:
1. Start with FBN1 sequencing (highest pre-test probability)
2. If negative, proceed to full connective tissue panel
3. Consider WES if panel negative

*Source: ClinGen via gene-disease validity, GTEx expression*

Phase 3.5: Expression & Tissue Context (ENHANCED)

3.5.1 Cell-Type Specific Expression (CELLxGENE)

def get_cell_type_expression(tu, gene_symbol, affected_tissues):
    """Get single-cell expression to validate tissue relevance."""

    # Get expression across cell types
    expression = tu.tools.CELLxGENE_get_expression_data(
        gene=gene_symbol,
        tissue=affected_tissues[0] if affected_tissues else "all"
    )

    # Get cell type metadata
    cell_metadata = tu.tools.CELLxGENE_get_cell_metadata(
        gene=gene_symbol
    )

    # Identify high-expression cell types
    high_expression = [
        ct for ct in expression
        if ct.get('mean_expression', 0) > 1.0  # TPM > 1
    ]

    return {
        'expression_data': expression,
        'high_expression_cells': high_expression,
        'total_cell_types': len(cell_metadata)
    }

Why it matters: Confirms candidate genes are expressed in disease-relevant tissues/cells.

3.5.2 Regulatory Context (ChIPAtlas)

def get_regulatory_context(tu, gene_symbol):
    """Get transcription factor binding for candidate genes."""

    # Search for TF binding near gene
    tf_binding = tu.tools.ChIPAtlas_enrichment_analysis(
        gene=gene_symbol,
        cell_type="all"
    )

    # Get specific binding peaks
    peaks = tu.tools.ChIPAtlas_get_peak_data(
        gene=gene_symbol,
        experiment_type="TF"
    )

    return {
        'transcription_factors': tf_binding,
        'regulatory_peaks': peaks
    }

Why it matters: Identifies regulatory mechanisms that may be disrupted in disease.

3.5.3 Output for Report

## 3.5 Expression & Regulatory Context

### Cell-Type Specific Expression (CELLxGENE)

| Gene | Top Expressing Cell Types | Expression Level | Tissue Relevance |
|------|---------------------------|------------------|------------------|
| FBN1 | Fibroblasts, Smooth muscle | High (TPM=45) | ✓ Connective tissue |
| TGFBR1 | Endothelial, Fibroblasts | Medium (TPM=12) | ✓ Vascular |
| COL3A1 | Fibroblasts, Myofibroblasts | Very High (TPM=120) | ✓ Connective tissue |

**Interpretation**: All top candidate genes show high expression in disease-relevant cell types (connective tissue, vascular cells), supporting their candidacy.

### Regulatory Context (ChIPAtlas)

| Gene | Key TF Regulators | Regulatory Significance |
|------|-------------------|------------------------|
| FBN1 | TGFβ pathway (SMAD2/3), AP-1 | TGFβ-responsive |
| TGFBR1 | STAT3, NF-κB | Inflammation-responsive |

*Source: CELLxGENE Census, ChIPAtlas*

Phase 3.6: Pathway Analysis (NEW)

3.6.1 KEGG Pathway Context

def get_pathway_context(tu, gene_symbols):
    """Get pathway context for candidate genes."""

    pathways = {}
    for gene in gene_symbols:
        # Search KEGG for gene
        kegg_genes = tu.tools.kegg_find_genes(query=f"hsa:{gene}")

        if kegg_genes:
            # Get pathway membership
            gene_info = tu.tools.kegg_get_gene_info(gene_id=kegg_genes[0]['id'])
            pathways[gene] = gene_info.get('pathways', [])

    return pathways

3.6.2 Protein-Protein Interactions (IntAct)

def get_protein_interactions(tu, gene_symbol):
    """Get interaction partners for candidate genes."""

    # Search IntAct for interactions
    interactions = tu.tools.intact_search_interactions(
        query=gene_symbol,
        species="human"
    )

    # Get interaction network
    network = tu.tools.intact_get_interaction_network(
        gene=gene_symbol,
        depth=1  # Direct interactors only
    )

    return {
        'interactions': interactions,
        'network': network,
        'interactor_count': len(interactions)
    }

3.6.3 Output for Report

## 3.6 Pathway & Network Context

### KEGG Pathways

| Gene | Key Pathways | Biological Process |
|------|--------------|-------------------|
| FBN1 | ECM-receptor interaction (hsa04512) | Extracellular matrix |
| TGFBR1/2 | TGF-beta signaling (hsa04350) | Cell signaling |
| COL3A1 | Focal adhesion (hsa04510) | Cell-matrix adhesion |

### Shared Pathway Analysis

**Convergent pathways** (≥2 candidate genes):
- TGF-beta signaling pathway: FBN1, TGFBR1, TGFBR2, SMAD3
- ECM organization: FBN1, COL3A1

**Interpretation**: Candidate genes converge on TGF-beta signaling and extracellular matrix pathways, consistent with connective tissue disorder etiology.

### Protein-Protein Interactions (IntAct)

| Gene | Direct Interactors | Notable Partners |
|------|-------------------|------------------|
| FBN1 | 42 | LTBP1, TGFB1, ADAMTS10 |
| TGFBR1 | 68 | TGFBR2, SMAD2, SMAD3 |

*Source: KEGG, IntAct, Reactome*

Phase 4: Variant Interpretation (If Provided)

4.1 ClinVar Lookup

def interpret_variant(tu, variant_hgvs):
    """Get ClinVar interpretation for variant."""
    result = tu.tools.ClinVar_search_variants(query=variant_hgvs)

    return {
        'clinvar_id': result.get('id'),
        'classification': result.get('clinical_significance'),
        'review_status': result.get('review_status'),
        'conditions': result.get('conditions'),
        'last_evaluated': result.get('last_evaluated')
    }

4.2 Population Frequency

def check_population_frequency(tu, variant_id):
    """Get gnomAD allele frequency."""
    freq = tu.tools.gnomAD_get_variant_frequencies(variant_id=variant_id)

    # Interpret rarity
    if freq['allele_frequency'] < 0.00001:
        rarity = "Ultra-rare"
    elif freq['allele_frequency'] < 0.0001:
        rarity = "Rare"
    elif freq['allele_frequency'] < 0.01:
        rarity = "Low frequency"
    else:
        rarity = "Common (likely benign)"

    return freq, rarity

4.3 Computational Pathogenicity Prediction (ENHANCED)

Use state-of-the-art prediction tools for VUS interpretation:

def comprehensive_vus_prediction(tu, variant_info):
    """
    Combine multiple prediction tools for VUS classification.
    Critical for rare disease variants not in ClinVar.
    """
    predictions = {}

    # 1. CADD - Deleteriousness (NEW API)
    cadd = tu.tools.CADD_get_variant_score(
        chrom=variant_info['chrom'],
        pos=variant_info['pos'],
        ref=variant_info['ref'],
        alt=variant_info['alt'],
        version="GRCh38-v1.7"
    )
    if cadd.get('status') == 'success':
        predictions['cadd'] = {
            'score': cadd['data'].get('phred_score'),
            'interpretation': cadd['data'].get('interpretation'),
            'acmg': 'PP3' if cadd['data'].get('phred_score', 0) >= 20 else 'neutral'
        }

    # 2. AlphaMissense - DeepMind pathogenicity (NEW)
    if variant_info.get('uniprot_id') and variant_info.get('aa_change'):
        am = tu.tools.AlphaMissense_get_variant_score(
            uniprot_id=variant_info['uniprot_id'],
            variant=variant_info['aa_change']  # e.g., "E1541K"
        )
        if am.get('status') == 'success' and am.get('data'):
            classification = am['data'].get('classification')
            predictions['alphamissense'] = {
                'score': am['data'].get('pathogenicity_score'),
                'classification': classification,
                'acmg': 'PP3 (strong)' if classification == 'pathogenic' else (
                    'BP4 (strong)' if classification == 'benign' else 'neutral'
                )
            }

    # 3. EVE - Evolutionary prediction (NEW)
    eve = tu.tools.EVE_get_variant_score(
        chrom=variant_info['chrom'],
        pos=variant_info['pos'],
        ref=variant_info['ref'],
        alt=variant_info['alt']
    )
    if eve.get('status') == 'success':
        eve_scores = eve['data'].get('eve_scores', [])
        if eve_scores:
            predictions['eve'] = {
                'score': eve_scores[0].get('eve_score'),
                'classification': eve_scores[0].get('classification'),
                'acmg': 'PP3' if eve_scores[0].get('eve_score', 0) > 0.5 else 'BP4'
            }

    # 4. SpliceAI - Splice variant prediction (NEW)
    # Use for intronic, synonymous, or exonic variants near splice sites
    variant_str = f"chr{variant_info['chrom']}-{variant_info['pos']}-{variant_info['ref']}-{variant_info['alt']}"
    splice = tu.tools.SpliceAI_predict_splice(
        variant=variant_str,
        genome="38"
    )
    if splice.get('data'):
        max_score = splice['data'].get('max_delta_score', 0)
        interpretation = splice['data'].get('interpretation', '')

        if max_score >= 0.8:
            splice_acmg = 'PP3 (strong) - high splice impact'
        elif max_score >= 0.5:
            splice_acmg = 'PP3 (moderate) - splice impact'
        elif max_score >= 0.2:
            splice_acmg = 'PP3 (supporting) - possible splice effect'
        else:
            splice_acmg = 'BP7 (if synonymous) - no splice impact'

        predictions['spliceai'] = {
            'max_delta_score': max_score,
            'interpretation': interpretation,
            'scores': splice['data'].get('scores', []),
            'acmg': splice_acmg
        }

    # Consensus for PP3/BP4
    damaging = sum(1 for p in predictions.values() if 'PP3' in p.get('acmg', ''))
    benign = sum(1 for p in predictions.values() if 'BP4' in p.get('acmg', ''))

    return {
        'predictions': predictions,
        'consensus': {
            'damaging_count': damaging,
            'benign_count': benign,
            'pp3_applicable': damaging >= 2 and benign == 0,
            'bp4_applicable': benign >= 2 and damaging == 0
        }
    }

4.4 ACMG Classification Criteria

Evidence TypeCriteriaWeight
PVS1Null variant in gene where LOF is mechanismVery Strong
PS1Same amino acid change as established pathogenicStrong
PM2Absent from population databasesModerate
PP3Computational evidence supports deleterious (AlphaMissense, CADD, EVE, SpliceAI)Supporting
BA1Allele frequency >5%Benign standalone

Enhanced PP3 Evidence (NEW):

  • AlphaMissense pathogenic (>0.564) = Strong PP3 support (~90% accuracy)
  • CADD ≥20 + EVE >0.5 = Multiple concordant predictions
  • Agreement from 2+ predictors strengthens PP3 evidence

4.5 Output for Report

## 4. Variant Interpretation

### 4.1 Variant: FBN1 c.4621G>A (p.Glu1541Lys)

| Property | Value | Interpretation |
|----------|-------|----------------|
| Gene | FBN1 | Marfan syndrome gene |
| Consequence | Missense | Amino acid change |
| ClinVar | VUS | Uncertain significance |
| gnomAD AF | 0.000004 | Ultra-rare (PM2) |

### 4.2 Computational Predictions (NEW)

| Predictor | Score | Classification | ACMG Support |
|-----------|-------|----------------|--------------|
| **AlphaMissense** | 0.78 | Pathogenic | PP3 (strong) |
| **CADD PHRED** | 28.5 | Top 0.1% deleterious | PP3 |
| **EVE** | 0.72 | Likely pathogenic | PP3 |

**Consensus**: 3/3 predictors concordant damaging → **Strong PP3 support**

*Source: AlphaMissense, CADD API, EVE via Ensembl VEP*

### 4.3 ACMG Evidence Summary

| Criterion | Evidence | Strength |
|-----------|----------|----------|
| PM2 | Absent from gnomAD (AF < 0.00001) | Moderate |
| PP3 | AlphaMissense + CADD + EVE concordant | Supporting (strong) |
| PP4 | Phenotype highly specific for Marfan | Supporting |
| PS4 | Multiple affected family members | Strong |

**Preliminary Classification**: Likely Pathogenic (1 Strong + 1 Moderate + 2 Supporting)

*Source: ClinVar, gnomAD, AlphaMissense, CADD, EVE*

Phase 5: Structure Analysis for VUS

5.1 When to Perform Structure Analysis

Perform when:

  • Variant is VUS or conflicting interpretations
  • Missense variant in critical domain
  • Novel variant not in databases
  • Additional evidence needed for classification

5.2 Structure Prediction (NVIDIA NIM)

def analyze_variant_structure(tu, protein_sequence, variant_position):
    """Predict structure and analyze variant impact."""

    # Predict structure with AlphaFold2
    structure = tu.tools.NvidiaNIM_alphafold2(
        sequence=protein_sequence,
        algorithm="mmseqs2",
        relax_prediction=False
    )

    # Extract pLDDT at variant position
    variant_plddt = get_residue_plddt(structure, variant_position)

    # Check if in structured region
    confidence = "High" if variant_plddt > 70 else "Low"

    return {
        'structure': structure,
        'variant_plddt': variant_plddt,
        'confidence': confidence
    }

5.3 Domain Impact Assessment

def assess_domain_impact(tu, uniprot_id, variant_position):
    """Check if variant affects functional domain."""

    # Get domain annotations
    domains = tu.tools.InterPro_get_protein_domains(accession=uniprot_id)

    for domain in domains:
        if domain['start'] <= variant_position <= domain['end']:
            return {
                'in_domain': True,
                'domain_name': domain['name'],
                'domain_function': domain['description']
            }

    return {'in_domain': False}

5.4 Output for Report

## 5. Structural Analysis

### 5.1 Structure Prediction

**Method**: AlphaFold2 via NVIDIA NIM
**Protein**: Fibrillin-1 (FBN1)
**Sequence Length**: 2,871 amino acids

| Metric | Value | Interpretation |
|--------|-------|----------------|
| Mean pLDDT | 85.3 | High confidence overall |
| Variant position pLDDT | 92.1 | Very high confidence |
| Nearby domain | cbEGF-like domain 23 | Calcium-binding |

### 5.2 Variant Location Analysis

**Variant**: p.Glu1541Lys

| Feature | Finding | Impact |
|---------|---------|--------|
| Domain | cbEGF-like domain 23 | Critical for calcium binding |
| Conservation | 100% conserved across vertebrates | High constraint |
| Structural role | Calcium coordination residue | Likely destabilizing |
| Nearby pathogenic | p.Glu1540Lys (Pathogenic) | Adjacent residue |

### 5.3 Structural Interpretation

The variant p.Glu1541Lys:
1. **Located in cbEGF domain** - These domains are critical for fibrillin-1 function
2. **Glutamate → Lysine** - Charge reversal (negative to positive)
3. **Calcium binding** - Glutamate at this position coordinates Ca2+
4. **Adjacent pathogenic variant** - p.Glu1540Lys is classified Pathogenic

**Structural Evidence**: Strong support for pathogenicity (PM1 - critical domain)

*Source: NVIDIA NIM via `NvidiaNIM_alphafold2`, InterPro*

Phase 6: Literature Evidence (NEW)

6.1 Published Literature (PubMed)

def search_disease_literature(tu, disease_name, genes):
    """Search for relevant published literature."""

    # Disease-specific search
    disease_papers = tu.tools.PubMed_search_articles(
        query=f'"{disease_name}" AND (genetics OR mutation OR variant)',
        limit=20
    )

    # Gene-specific searches
    gene_papers = []
    for gene in genes[:5]:  # Top 5 genes
        papers = tu.tools.PubMed_search_articles(
            query=f'"{gene}" AND rare disease AND pathogenic',
            limit=10
        )
        gene_papers.extend(papers)

    return {
        'disease_literature': disease_papers,
        'gene_literature': gene_papers
    }

6.2 Preprint Literature (BioRxiv/MedRxiv)

def search_preprints(tu, disease_name, genes):
    """Search preprints for cutting-edge findings."""

    # BioRxiv search
    biorxiv = tu.tools.BioRxiv_search_preprints(
        query=f"{disease_name} genetics",
        limit=10
    )

    # ArXiv for computational methods
    arxiv = tu.tools.ArXiv_search_papers(
        query=f"rare disease diagnosis {' OR '.join(genes[:3])}",
        category="q-bio",
        limit=5
    )

    return {
        'biorxiv': biorxiv,
        'arxiv': arxiv
    }

6.3 Citation Analysis (OpenAlex)

def analyze_citations(tu, key_papers):
    """Analyze citation network for key papers."""

    citation_analysis = []
    for paper in key_papers[:5]:
        # Get citation data
        work = tu.tools.openalex_search_works(
            query=paper['title'],
            limit=1
        )
        if work:
            citation_analysis.append({
                'title': paper['title'],
                'citations': work[0].get('cited_by_count', 0),
                'year': work[0].get('publication_year')
            })

    return citation_analysis

6.4 Output for Report

## 6. Literature Evidence

### 6.1 Key Published Studies

| PMID | Title | Year | Citations | Relevance |
|------|-------|------|-----------|-----------|
| 32123456 | FBN1 variants in Marfan syndrome... | 2023 | 45 | Direct |
| 31987654 | TGF-beta signaling in connective... | 2022 | 89 | Pathway |
| 30876543 | Novel diagnostic criteria for... | 2021 | 156 | Diagnostic |

### 6.2 Recent Preprints (Not Yet Peer-Reviewed)

| Source | Title | Posted | Relevance |
|--------|-------|--------|-----------|
| BioRxiv | Novel FBN1 splice variant causes... | 2024-01 | Case report |
| MedRxiv | Machine learning for Marfan... | 2024-02 | Diagnostic |

**⚠️ Note**: Preprints have not undergone peer review. Use with caution.

### 6.3 Evidence Summary

| Evidence Type | Count | Strength |
|---------------|-------|----------|
| Case reports | 12 | Supporting |
| Functional studies | 5 | Strong |
| Clinical trials | 2 | Strong |
| Reviews | 8 | Context |

*Source: PubMed, BioRxiv, OpenAlex*

Report Template

File: [PATIENT_ID]_rare_disease_report.md

# Rare Disease Diagnostic Report

**Patient ID**: [ID] | **Date**: [Date] | **Status**: In Progress

---

## Executive Summary
[Researching...]

---

## 1. Phenotype Analysis
### 1.1 Standardized HPO Terms
[Researching...]
### 1.2 Key Clinical Features
[Researching...]

---

## 2. Differential Diagnosis
### 2.1 Ranked Candidate Diseases
[Researching...]
### 2.2 Disease Details
[Researching...]

---

## 3. Recommended Gene Panel
### 3.1 Prioritized Genes
[Researching...]
### 3.2 Testing Strategy
[Researching...]

---

## 4. Variant Interpretation (if applicable)
### 4.1 Variant Details
[Researching...]
### 4.2 ACMG Classification
[Researching...]

---

## 5. Structural Analysis (if applicable)
### 5.1 Structure Prediction
[Researching...]
### 5.2 Variant Impact
[Researching...]

---

## 6. Clinical Recommendations
### 6.1 Diagnostic Next Steps
[Researching...]
### 6.2 Specialist Referrals
[Researching...]
### 6.3 Family Screening
[Researching...]

---

## 7. Data Gaps & Limitations
[Researching...]

---

## 8. Data Sources
[Will be populated as research progresses...]

Evidence Grading

TierSymbolCriteriaExample
T1★★★Phenotype match >80% + gene matchMarfan with FBN1 mutation
T2★★☆Phenotype match 60-80% OR likely pathogenic variantGood phenotype fit
T3★☆☆Phenotype match 40-60% OR VUS in candidate genePossible diagnosis
T4☆☆☆Phenotype <40% OR uncertain geneLow probability

Completeness Checklist

Phase 1: Phenotype

  • All symptoms converted to HPO terms
  • Core vs. variable features distinguished
  • Age of onset documented
  • Family history noted

Phase 2: Disease Matching

  • ≥5 candidate diseases identified (or all matching)
  • Phenotype overlap % calculated
  • Inheritance patterns noted
  • ORPHA and OMIM IDs provided

Phase 3: Gene Panel

  • ≥5 genes prioritized (or all from top diseases)
  • Evidence level for each gene (ClinGen)
  • Expression validation performed
  • Testing strategy recommended

Phase 4: Variant Interpretation (if applicable)

  • ClinVar classification retrieved
  • gnomAD frequency checked
  • ACMG criteria applied
  • Classification justified

Phase 5: Structure Analysis (if applicable)

  • Structure predicted (if VUS)
  • pLDDT confidence reported
  • Domain impact assessed
  • Structural evidence summarized

Phase 6: Recommendations

  • ≥3 next steps listed
  • Specialist referrals suggested
  • Family screening addressed

Fallback Chains

Primary ToolFallback 1Fallback 2
Orphanet_search_by_hpoOMIM_searchPubMed phenotype search
ClinVar_get_variantgnomAD_get_variantVEP annotation
NvidiaNIM_alphafold2alphafold_get_predictionUniProt features
GTEx_expressionHPA_expressionTissue-specific literature
gnomAD_get_variantExAC_frequencies1000 Genomes

Tool Reference

See TOOLS_REFERENCE.md for complete tool documentation.

平台分布

Codex

36.05%
按下载量换算36

Claude

33.04%
按下载量换算33

Cursor

17.52%
按下载量换算17

Gemini CLI

9.25%
按下载量换算9

安全审计

Gen Agent Trust Hub

通过

Socket

通过

Snyk

可疑

权限和风险

需要联网

该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。来源安全扫描存在提醒或未通过项,安装前请自行复核。目前只有一个公开来源,建议同时核对源仓库。

继续浏览同类 Skills